Posizioni attive di Dennis J. Church
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Corporate Officer/Principal | 17/11/2009 | - |
Storia della carriera di Dennis J. Church
Precedenti posizioni note di Dennis J. Church
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Svizzera | 3 |
Posizioni
| Corporate Officer/Principal | 2 |
Settori
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute |
- Borsa valori
- Insiders
- Dennis J. Church
- Esperienza
